Literature DB >> 18776939

TNF-alpha and TLR agonists increase susceptibility to HIV-1 transmission by human Langerhans cells ex vivo.

Marein A W P de Jong1, Lot de Witte, Menno J Oudhoff, Sonja I Gringhuis, Philippe Gallay, Teunis B H Geijtenbeek.   

Abstract

Genital coinfections increase an individual's risk of becoming infected with HIV-1 by sexual contact. Several mechanisms have been proposed to explain this, such as the presence of ulceration and bleeding caused by the coinfecting pathogen. Here we demonstrate that Langerhans cells (LCs) are involved in the increased susceptibility to HIV-1 in the presence of genital coinfections. Although LCs are a target for HIV-1 infection in genital tissues, we found that immature LCs did not efficiently mediate HIV-1 transmission in an ex vivo human skin explant model. However, the inflammatory stimuli TNF-alpha and Pam3CysSerLys4 (Pam3CSK4), the ligand for the TLR1/TLR2 heterodimer, strongly increased HIV-1 transmission by LCs through distinct mechanisms. TNF-alpha enhanced transmission by increasing HIV-1 replication in LCs, whereas Pam3CSK4 acted by increasing LC capture of HIV-1 and subsequent trans-infection of T cells. Genital infections such as Candida albicans and Neisseria gonorrhea not only triggered TLRs but also induced TNF-alpha production in vaginal and skin explants. Thus, during coinfection, LCs could be directly activated by pathogenic structures and indirectly activated by inflammatory factors, thereby increasing the risk of acquiring HIV-1. Our data demonstrate a decisive role for LCs in HIV-1 transmission during genital coinfections and suggest antiinflammatory therapies as potential strategies to prevent HIV-1 transmission.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18776939      PMCID: PMC2528910          DOI: 10.1172/JCI34721

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  54 in total

1.  The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors.

Authors:  A Ozinsky; D M Underhill; J D Fontenot; A M Hajjar; K D Smith; C B Wilson; L Schroeder; A Aderem
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

2.  Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells.

Authors:  Z Zhang; T Schuler; M Zupancic; S Wietgrefe; K A Staskus; K A Reimann; T A Reinhart; M Rogan; W Cavert; C J Miller; R S Veazey; D Notermans; S Little; S A Danner; D D Richman; D Havlir; J Wong; H L Jordan; T W Schacker; P Racz; K Tenner-Racz; N L Letvin; S Wolinsky; A T Haase
Journal:  Science       Date:  1999-11-12       Impact factor: 47.728

3.  Low levels of productive HIV infection in Langerhans cell-like dendritic cells differentiated in the presence of TGF-beta1 and increased viral replication with CD40 ligand-induced maturation.

Authors:  T Kawamura; M Qualbani; E K Thomas; J M Orenstein; A Blauvelt
Journal:  Eur J Immunol       Date:  2001-02       Impact factor: 5.532

4.  Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.

Authors:  Xiping Wei; Julie M Decker; Hongmei Liu; Zee Zhang; Ramin B Arani; J Michael Kilby; Michael S Saag; Xiaoyun Wu; George M Shaw; John C Kappes
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

5.  Binding specificity of siglec7 to disialogangliosides of renal cell carcinoma: possible role of disialogangliosides in tumor progression.

Authors:  A Ito; K Handa; D A Withers; M Satoh; S Hakomori
Journal:  FEBS Lett       Date:  2001-06-01       Impact factor: 4.124

6.  Lewis X component in human milk binds DC-SIGN and inhibits HIV-1 transfer to CD4+ T lymphocytes.

Authors:  Marloes A Naarding; Irene S Ludwig; Fedde Groot; Ben Berkhout; Teunis B H Geijtenbeek; Georgios Pollakis; William A Paxton
Journal:  J Clin Invest       Date:  2005-10-20       Impact factor: 14.808

7.  Memory CD4(+) T cells are the earliest detectable human immunodeficiency virus type 1 (HIV-1)-infected cells in the female genital mucosal tissue during HIV-1 transmission in an organ culture system.

Authors:  Phalguni Gupta; Kelly B Collins; Deena Ratner; Simon Watkins; Gregory J Naus; Daniel V Landers; Bruce K Patterson
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

8.  Monoclonal antibody (5F3) defining renal cell carcinoma-associated antigen disialosyl globopentaosylceramide (V3NeuAcIV6NeuAcGb5), and distribution pattern of the antigen in tumor and normal tissues.

Authors:  A Ito; S Saito; T Masuko; M Oh-Eda; T Matsuura; M Satoh; F M Nejad; T Enomoto; S Orikasa; S I Hakomori
Journal:  Glycoconj J       Date:  2001-06       Impact factor: 2.916

9.  Susceptibility to human immunodeficiency virus-1 infection of human foreskin and cervical tissue grown in explant culture.

Authors:  Bruce K Patterson; Alan Landay; Joan N Siegel; Zareefa Flener; Dennis Pessis; Antonio Chaviano; Robert C Bailey
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

10.  Candidate microbicides block HIV-1 infection of human immature Langerhans cells within epithelial tissue explants.

Authors:  T Kawamura; S S Cohen; D L Borris; E A Aquilino; S Glushakova; L B Margolis; J M Orenstein; R E Offord; A R Neurath; A Blauvelt
Journal:  J Exp Med       Date:  2000-11-20       Impact factor: 14.307

View more
  64 in total

1.  HIV-1 exploits innate signaling by TLR8 and DC-SIGN for productive infection of dendritic cells.

Authors:  Sonja I Gringhuis; Michiel van der Vlist; Linda M van den Berg; Jeroen den Dunnen; Manja Litjens; Teunis B H Geijtenbeek
Journal:  Nat Immunol       Date:  2010-04-04       Impact factor: 25.606

2.  Activation of human macrophages by bacterial components relieves the restriction on replication of an interferon-inducing parainfluenza virus 5 (PIV5) P/V mutant.

Authors:  Caitlin M Briggs; Robert C Holder; Sean D Reid; Griffith D Parks
Journal:  Microbes Infect       Date:  2010-12-24       Impact factor: 2.700

3.  Vpr Enhances Tumor Necrosis Factor Production by HIV-1-Infected T Cells.

Authors:  Ferdinand Roesch; Léa Richard; Réjane Rua; Françoise Porrot; Nicoletta Casartelli; Olivier Schwartz
Journal:  J Virol       Date:  2015-09-23       Impact factor: 5.103

4.  Cervico-vaginal tissue ex vivo as a model to study early events in HIV-1 infection.

Authors:  Melanie Merbah; Andrea Introini; Wendy Fitzgerald; Jean-Charles Grivel; Andrea Lisco; Christophe Vanpouille; Leonid Margolis
Journal:  Am J Reprod Immunol       Date:  2011-01-12       Impact factor: 3.886

Review 5.  The role of human dendritic cells in HIV-1 infection.

Authors:  Zahra Ahmed; Tatsuyoshi Kawamura; Shinji Shimada; Vincent Piguet
Journal:  J Invest Dermatol       Date:  2014-11-19       Impact factor: 8.551

Review 6.  The role of dendritic cells in driving genital tract inflammation and HIV transmission risk: are there opportunities to intervene?

Authors:  Muki S Shey; Nigel J Garrett; Lyle R McKinnon; Jo-Ann S Passmore
Journal:  Innate Immun       Date:  2013-11-26       Impact factor: 2.680

7.  PPARgamma and LXR signaling inhibit dendritic cell-mediated HIV-1 capture and trans-infection.

Authors:  Timothy M Hanley; Wendy Blay Puryear; Suryaram Gummuluru; Gregory A Viglianti
Journal:  PLoS Pathog       Date:  2010-07-01       Impact factor: 6.823

8.  The synthetic bacterial lipopeptide Pam3CSK4 modulates respiratory syncytial virus infection independent of TLR activation.

Authors:  D Tien Nguyen; Lot de Witte; Martin Ludlow; Selma Yüksel; Karl-Heinz Wiesmüller; Teunis B H Geijtenbeek; Albert D M E Osterhaus; Rik L de Swart
Journal:  PLoS Pathog       Date:  2010-08-19       Impact factor: 6.823

Review 9.  HIV interactions with monocytes and dendritic cells: viral latency and reservoirs.

Authors:  Christopher M Coleman; Li Wu
Journal:  Retrovirology       Date:  2009-06-01       Impact factor: 4.602

10.  The effects of circumcision on the penis microbiome.

Authors:  Lance B Price; Cindy M Liu; Kristine E Johnson; Maliha Aziz; Matthew K Lau; Jolene Bowers; Jacques Ravel; Paul S Keim; David Serwadda; Maria J Wawer; Ronald H Gray
Journal:  PLoS One       Date:  2010-01-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.